Most clinics will skip this. We won't. Here's exactly who qualifies for each OPTML protocol, who shouldn't be on it, and what we screen for at intake.
Eligibility, MTC/MEN2 history, pancreatitis, gallbladder, pregnancy, and the screening labs we require.
Read full screening →Why microdose has a wider eligibility window, and the cases where it still isn't right.
Read full screening →Hematocrit, PSA, fertility plans, prostate cancer history, sleep apnea, and the labs we need to see.
Read full screening →Who enclomiphene is built for, why it's the fertility-sparing option, and when TRT is still the better path.
Read full screening →VTE history, breast cancer, undiagnosed bleeding, migraines with aura, and the timing question that matters.
Read full screening →Active malignancy, severe illness, and why we screen IGF-1 before and during therapy.
Read full screening →The contraindication list is short, but the conditions matter. Histamine, pregnancy, and active cancer.
Read full screening →